Anavex Life Sciences Corp.

LSE:0HFR Stock Report

Market Cap: US$299.7m

Anavex Life Sciences Management

Management criteria checks 3/4

Anavex Life Sciences' CEO is Chris Missling, appointed in Jul 2013, has a tenure of 10.83 years. total yearly compensation is $3.89M, comprised of 18% salary and 82% bonuses, including company stock and options. directly owns 1.52% of the company’s shares, worth $4.56M. The average tenure of the management team and the board of directors is 2.7 years and 10.4 years respectively.

Key information

Chris Missling

Chief executive officer

US$3.9m

Total compensation

CEO salary percentage18.0%
CEO tenure10.8yrs
CEO ownership1.5%
Management average tenure2.7yrs
Board average tenure10.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chris Missling's remuneration changed compared to Anavex Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$43m

Sep 30 2023US$4mUS$700k

-US$48m

Jun 30 2023n/an/a

-US$52m

Mar 31 2023n/an/a

-US$53m

Dec 31 2022n/an/a

-US$50m

Sep 30 2022US$7mUS$586k

-US$48m

Jun 30 2022n/an/a

-US$45m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021n/an/a

-US$41m

Sep 30 2021US$9mUS$550k

-US$38m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020n/an/a

-US$28m

Sep 30 2020US$2mUS$550k

-US$26m

Jun 30 2020n/an/a

-US$26m

Mar 31 2020n/an/a

-US$26m

Dec 31 2019n/an/a

-US$26m

Sep 30 2019US$3mUS$513k

-US$26m

Jun 30 2019n/an/a

-US$26m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018n/an/a

-US$20m

Sep 30 2018US$3mUS$500k

-US$17m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$18m

Dec 31 2017n/an/a

-US$14m

Sep 30 2017US$3mUS$500k

-US$13m

Compensation vs Market: Chris's total compensation ($USD3.89M) is above average for companies of similar size in the UK market ($USD775.47K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.

CEO

Chris Missling (57 yo)

10.8yrs

Tenure

US$3,894,453

Compensation

Dr. Christopher U. Missling, also known as the Chris, MS, Ph D., MBA, has been the Chief Executive Officer and President at Anavex Life Sciences Corp. since July 05, 2013 and also serves as its Director an...

Leadership Team

NamePositionTenureCompensationOwnership
Christopher Missling
President10.8yrsUS$3.89m1.52%
$ 4.6m
Sandra Boenisch
Principal Financial Officer & Treasurer8.6yrsUS$501.06k0.028%
$ 83.8k
Stephan Toutain
Senior VP of Operations & COO6.2yrsno datano data
Walter Kaufmann
Chief Scientific Officer2.3yrsno datano data
Clint Tomlinson
VP of Corporateno datano datano data
Adebayo Laniyonu
Senior Vice President of Nonclinical Development3yrsno datano data
Edward Hammond
Chief Medical Officer2.3yrsno datano data
Kun Jin
Head of Biostatistics1.2yrsno datano data
David Goldberger
Senior Vice President of Regulatory Affairsless than a yearno datano data

2.7yrs

Average Tenure

57yo

Average Age

Experienced Management: 0HFR's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christopher Missling
President10.8yrsUS$3.89m1.52%
$ 4.6m
Jeffrey Cummings
Member of the Scientific Advisory Board13.2yrsno datano data
Jiong Ma
Independent Chairman3yrsUS$349.54k0%
$ 0
Jacqueline A. French
Member of the Scientific Advisory Board9.2yrsno datano data
Paul Aisen
Member of the Scientific Advisory Board13.3yrsno datano data
John Harrison
Member of the Scientific Advisory Board10.4yrsno datano data
Ottavio Arancio
Member of the Scientific Advisory Board10.5yrsno datano data
Tangui Maurice
Member of the Scientific Advisory Boardno datano datano data
Athanasios Skarpelos
Independent Director11.3yrsUS$341.54k1.59%
$ 4.8m
Norman Relkin
Member of the Scientific Advisory Board10yrsno datano data
Corinne Lasmézas
Member of the Scientific Advisory Board9.2yrsno datano data
Claus van der Velden
Lead Independent Director6.2yrsUS$357.54k0%
$ 0

10.4yrs

Average Tenure

57yo

Average Age

Experienced Board: 0HFR's board of directors are seasoned and experienced ( 10.4 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.